<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Detail Page</title>
    <link rel="stylesheet" href="../details.css">

    <meta name="citation_title" content="Design Of New Inhibitor Compounds Against SARS-COV-2 Main Protease Using Computer-Assisted Retrosynthetic Methods">
    <meta name="citation_author" content="Deniz CEYHAN">

    <meta name="citation_publication_date" content="21.05.2025">
    <meta name="citation_journal_title" content="Journal of Balkan Science and Technology (JBST)">
    <meta name="citation_volume" content="4">
    <meta name="citation_issue" content="1">



    <meta name="citation_firstpage" content="1">

    <meta name="citation_lastpage" content="8">

    <meta name="citation_pdf_url" content="https://jbst-nku.github.io/articles/2025_4_1_1.pdf">




</head>
<body>

<div class="det-page-container">
    <div class="detail-container">
        <div class="det-article-type">Research Article</div>
        <div class="det-title">Retrosyntetic Design of SARS-COV-2 Main Protease Inhibitors</div>
        <div class="volume-issn-container">
            <div class="det-year"> 2025</div>
            <div class="det-volume"> 4</div>
            <div class="det-issue"> 1</div>
            <div class="det-page"> 1-8</div>
            <div class="det-date"> 21.05.2025
            </div>

            <div class="det-eissn"> 2822-4566</div>
        </div>

        <div class="author-container">
            <div class="det-author">Deniz CEYHAN</div>

        </div>

        <div class="doi-pdf-container">
            <div class="det-doi"><a href="https://www.doi.org/10.55848/jbst.2025.06
">10.55848/jbst.2025.06
            </a></div>
            <a class="det-pdf" href="../articles/2025_4_1_1.pdf"><img class="pdf" src="../images/pdf.png"></a>
        </div>

        <div class="det-abstract">SARS-CoV-2 is the pathogen that caused the COVID-19 (coronavirus disease 2019) pandemic. While effective vaccines have been developed, there is still an urgent need to develop antiviral drugs for post- infection treatment. This study focuses on the design of novel inhibitory compounds against the SARS- CoV-2 main protease, a key enzyme in viral replication. Reported Mpro inhibitor compounds were fragmented using computer-assisted retrosynthetic methods, and new inhibitors were designed from these fragments following synthesizability rules. The binding affinities of the newly designed compounds were analyzed through docking calculations, and the top 5 compounds showed higher binding affinities than previously described inhibitors, with docking scores ranging from -11.67 to -12.51 kcal/mol. Similarity searches on PubChem revealed that these designed compounds are 83-95% similar to a large number of existing commercially available proprietary compounds, indicating limited novelty but potentially improved synthetic accessibility. This study demonstrates the potential of computer-assisted retrosynthetic design to rapidly generate new, synthetically feasible inhibitor candidates for further optimization and development as SARS-CoV-2 antiviral therapeutics.
        </div>
        <div class="det-keywords det-datex-header">
            SARS-CoV-2,
            COVID-19,
            Main protease,
            Inhibitor design,
            Retrosynthesis,
            Molecular docking</div>
        <div class="det-correspondence">Deniz CEYHAN<a class="def-correspondence-email" href="dceyhan@nku.edu.tr">dceyhan@nku.edu.tr</a></div>
        <div class="det-received-date det-datex-header"> 16.01.2025</div>
        <div class="det-accepted-date det-datex-header"> 22.03.2025</div>
        <div class="det-published-date det-datex-header">19.05.2025</div>
        <div class="det-cite det-datex-header"> Deniz CEYHAN JBST. December 2024.59-64 http://10.55848/jbst.2025.01</div>
        <div class="det-license" style="font-size: 1.5vw"> This work is licensed under a Creative Commons Attribution-Non Comercial 4.0 International License.</div>
        <a rel="license" href="http://creativecommons.org/licenses/by-nc/4.0/"><img alt="Creative Commons License" style="border-width:0" src="https://i.creativecommons.org/l/by-nc/4.0/88x31.png" /></a><a rel="license" href="http://creativecommons.org/licenses/by-nc/4.0/"></a>

        <div><a href="https://jbst-nku.github.io/">Return to JSBT Archive</a></div>
        <div><a href="http://jbst.nku.edu.tr/">Return to JSBT Main Page</a></div>
    </div>
</div>
</body>
</html>